Interest Rates Can't Touch These 3 Stocks (One is Up 540%)
About this episode
Marc Lichtenfeld discusses three healthcare stocks that are resilient to interest rate changes.
Get a Special Discount on the Oxford Income Letter: https://www.marketbeat.com/y/yt978/ Drug prices are back in the headlines, but the healthcare and biotech sector has been quietly delivering some of the strongest returns in the market this year, including one name up nearly 500% in a year. Marc Lichtenfeld of the Oxford Club joins the show to break down why healthcare tends to be interest rate neutral and share his top three picks: a short-term technical setup, a mid-term catalyst play, and a long-term dividend growth story. Lichtenfeld covers chart patterns, short interest and squeeze potential, upcoming phase three trial data, and why some biotech names get acquired at massive premiums, plus why blue-chip pharma can offer both growth and reliable dividend increases. Chapters: 00:00 Introduction 02:58 Why Healthcare Is Interest Rate Neutral 06:37 Stock 1 16:29 Stock 2 26:14 Stock 3 Let me know in the comments which of these three picks you're most interested in. 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We…
Sponsors
Oxford Income Letter
More episodes of MarketBeat | Stock Market News & Analysis
- The Fed Won't Tell You What's Next (3 Stocks to Survive the Storm)
- Palantir Just Became Almost Impossible to Replace (This Changes EVERYTHING for the Stock)
- 3 Critical Materials Stocks Under $20 to Buy Now
- It's Happening Again: Wall Street Is All In on One Sector (5 Stocks to Buy Now)
- The UNTHINKABLE is About to Happen to Copper (& Why These 3 Stocks Could Triple)
- This Hasn't Happened in 25 Years (Your Investments ARE NOT Ready For What's Coming)
Explore listener stats, chart rankings, contacts and more on the MarketBeat | Stock Market News & Analysis podcast page.